| Financial Year |
March 31 2023 |
| Monetary Funds |
113,335,028,304.77 |
| Held-for-trading Financial Assets |
3,529,772,992.11 |
| Notes Receivable |
143,182,793.10 |
| Accounts Receivable |
17,139,168,008.51 |
| Advances to Suppliers |
70,671,237,069.90 |
| Other Receivables |
79,046,702,813.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
108,015,480.71 |
| Inventories |
389,703,292,370.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,891,308,013.16 |
| Other Current Assets |
21,894,726,002.19 |
| Total Current Assets |
700,582,525,559.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,305,073,073.34 |
| Long-term Equity Investment |
26,124,509,636.11 |
| Investment Properties |
15,523,814,535.52 |
| Fixed Assetes |
3,964,757,260.20 |
| Under-construction Projects |
2,776,927,335.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,150,179,065.12 |
| R&D expenses |
11,370,131.71 |
| Goodwill |
896,490,002.45 |
| Long-Term Deferred and Prepaid Expenses |
568,062,344.72 |
| Deferred Income Tax Assets |
12,027,732,422.09 |
| Other Non-Current Assets |
1,438,216,785.69 |
| Sub-Total of Non-Current Assets |
69,864,950,761.70 |
| Total Assets |
770,447,476,321.47 |
| Short-Term Loans |
40,367,708,043.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
33,091,266,649.45 |
| Accounts Payable |
45,939,005,124.08 |
| Accounts Received In Advance |
88,819,217.69 |
| Employee Compensation Payable |
2,997,373,167.63 |
| Taxes Payable |
6,623,187,549.64 |
| Interest Payable |
-- |
| Dividend Payable |
128,835,715.36 |
| Other payables |
41,553,213,768.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,730,913,910.85 |
| Other Current Liabilities |
28,724,508,528.33 |
| Sub-Total of Current Liabilities |
494,259,275,679.40 |
| Long-term Loans |
57,437,766,168.26 |
| Bonds Payable |
36,829,358,676.88 |
| Long-Term Accounts Payable |
129,855,777.37 |
| Special Payable |
-- |
| Estimatied Liabilities |
292,878,682.44 |
| Deferred Income Tax Liabilities |
4,120,575,409.03 |
| Other Non-Current Liabilities |
12,536,200,000.00 |
| Sub-Total of Non-Current Liabilities |
112,125,613,490.71 |
| Total Liabilities |
606,384,889,170.11 |
| Paid-In Capital(Or Share Stock) |
3,005,171,030.00 |
| Capital Surplus |
4,552,177,841.85 |
| Surplus Reserve |
1,588,674,762.06 |
| LESS:Treasury Stock |
901,610,087.64 |
| Undistributed Profits |
37,739,040,219.94 |
| Minority Stockholder's Interest |
106,497,576,709.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
57,565,010,441.71 |
| Owner's Equity（Stockholder's Equity） |
164,062,587,151.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
770,447,476,321.47 |
